Antiparkinson drugs as causal agents in tardive dyskinesia.
D000978:Antiparkinson Agents / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001590:Benztropine / Q000009:adverse effects; D004357:Drug Synergism; D005260:Female; D005476:Fluphenazine / Q000009:adverse effects; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced*; D010640:Phenothiazines / Q000009:adverse effects; D014326:Tropanes / Q000009:adverse effects*
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D010640:Phenothiazines; D014326:Tropanes; D001590:Benztropine; D006220:Haloperidol; D005476:Fluphenazine